What is the primary objective of ISO 27001?

ISO 27001's primary objective is to establish, implement, maintain, and continually improve an Information Security Management System (ISMS) to manage information security risks systematically. It protects the confidentiality, integrity, and availability of information assets using a risk-based approach via Clauses 4–10 and 93 Annex A controls (2022 edition, grouped into Organizational, People, Physical, and Technological themes).

Who is legally or professionally required to comply with ISO 27001?

ISO 27001 is voluntary and applies to all organizations regardless of size, type, or sector handling information assets. No legal mandates exist, but it is professionally required for regulated sectors (finance, healthcare, government) via contractual clauses, RFPs, and supply-chain demands; over 60,000 global certifications signal market expectations for C-suite, IT/security teams, and vendors.

Does ISO 27001 require an external audit or third-party certification?

ISO 27001 requires external audits by accredited certification bodies for formal certification, conducted in two stages. Stage 1 reviews documentation (scope, risk assessment, SoA); Stage 2 verifies implementation effectiveness via interviews and evidence. Certification lasts 3 years with annual surveillance audits and recertification.

How often should an assessment for ISO 27001 be performed?

Risk assessments under ISO 27001 must be performed at planned intervals and whenever significant changes occur. Internal audits occur per Clause 9.2 program (typically annually, risk-based); management reviews per Clause 9.3 (at least annually); surveillance audits annually post-certification.

What are the consequences of non-compliance with ISO 27001?

Non-compliance with ISO 27001 yields no direct penalties as it is voluntary, but exposes organizations to indirect risks like regulatory fines under enabling laws (e.g., GDPR up to 4% revenue), operational disruptions (average breach cost over USD 5M per recent industry reports), lost tenders, cyber insurance denials, and reputational damage.

Can ISO 27001 be mapped to other international frameworks?

Yes, ISO 27001 maps directly to frameworks like NIST CSF, CIS Controls, PCI-DSS, and SOX via Annex A controls and shared risk-based principles. Its Annex SL structure aligns with ISO 9001/22301 for integrated management systems; mappings facilitate multi-compliance efficiency.

What is the first step to begin implementing ISO 27001?

The first step is securing leadership commitment and defining ISMS scope per Clause 4 (context, interested parties). Form a steering committee, appoint an ISMS manager, conduct gap analysis against Clauses 4–10/Annex A, and produce a project charter with Gantt chart (1–2 months).

What is the primary objective of FDA 21 CFR Part 11?

FDA 21 CFR Part 11 establishes criteria under which the Agency considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures (§11.1(a)). It applies to electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, ensuring authenticity, integrity, confidentiality (when appropriate), and non-repudiation through controls like validation (§11.10(a)), audit trails (§11.10(e)), and signature linking (§11.70).

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Organizations using electronic records in lieu of paper for predicate-rule-required records, relying on electronic records for regulated activities, submitting accepted electronic records to FDA, or using legally binding electronic signatures must comply (§11.1(b)). This includes pharmaceutical, biotech, medical device, and certain food/veterinary firms; paper printouts relied upon as official records may exclude systems if documented.

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

No, FDA 21 CFR Part 11 does not require external audits or third-party certification. Compliance is demonstrated through internal validation (§11.10(a)), SOPs, training (§11.10(i)), and inspection readiness (§11.1(e)), with systems and documentation readily available for FDA review; predicate rules remain enforceable.

How often should an assessment for FDA 21 CFR Part 11 be performed?

Part 11 does not prescribe a fixed frequency for assessments; organizations must use risk-based periodic reviews tied to change control and predicate rules. FDA’s 2003 guidance supports ongoing validation lifecycle management, with reassessments triggered by system changes, periodic audits, or inspection findings to ensure fitness for use.

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Non-compliance with FDA 21 CFR Part 11 can result in FDA enforcement actions including Form 483 observations, warning letters, product holds, recalls, and fines under predicate rules. Even with enforcement discretion on some elements (e.g., validation, audit trails), failures in enforced controls like access (§11.10(d)) or signatures lead to data integrity violations and regulatory sanctions.

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

FDA 21 CFR Part 11 is not explicitly mapped to other frameworks in its text or 2003 guidance; compliance stands alone based on predicate rules. Organizations may align controls risk-based but must meet Part 11 specifics independently, without regulatory harmonization stated.

What is the first step to begin implementing FDA 21 CFR Part 11?

The first step is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic records versus paper. Document decisions in SOPs per FDA’s 2003 narrow scope guidance to define in-scope systems (closed/open) and prioritize controls like access and signatures.

Standards Comparison

ISO 27001 vs FDA 21 CFR Part 11

ISO 27001

Voluntary

2022

International standard for information security management systems

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for electronic records and signatures equivalence.

Quick Verdict

ISO 27001 provides voluntary ISMS certification for global security resilience, while FDA 21 CFR Part 11 mandates controls for trustworthy electronic records/signatures in US life sciences. Companies adopt ISO for broad compliance, Part 11 for regulatory necessity.

Cybersecurity

ISO 27001

ISO/IEC 27001:2022

Cost

€€€€

Complexity

High

Implementation Time

6-12 months

Key Features

Risk-based approach to ISMS implementation
PDCA cycle for continual improvement
93 Annex A controls in four themes
Technology-agnostic and industry-scalable framework
Internationally recognized certification standard

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11 Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Secure audit trails for all record changes
Closed and open system controls
Electronic signature linking and manifestation
Risk-based system validation requirements
Access, authority, and device checks

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

ISO 27001 Details

What It Is

ISO/IEC 27001:2022 is the international certification standard for establishing, implementing, maintaining, and improving an Information Security Management System (ISMS). It provides a systematic, risk-based framework to manage information risks across confidentiality, integrity, and availability, applicable to all organization sizes and industries.

Key Components

Mandatory Clauses 4-10 cover context, leadership, planning, support, operation, evaluation, and improvement.
Annex A includes 93 controls grouped into organizational (37), people (8), physical (14), and technological (34) themes.
Built on PDCA cycle for continual improvement.
Optional certification via accredited auditors with Stage 1/2 audits, surveillance, and recertification.

Why Organizations Use It

Enhances resilience against breaches, reduces incident costs (avg. over $5M).
Meets regulatory/contractual needs (e.g., GDPR, NIS2); voluntary but often required for tenders.
Drives competitive edges like 20-30% more bids won, insurance discounts.
Builds stakeholder trust via independent certification.

Implementation Overview

Phased approach: initiation, risk assessment, control deployment, audits (6-18 months). Scalable for SMEs/enterprises; requires leadership, training, documentation.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. federal regulation establishing criteria for electronic records and electronic signatures to be considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule-required records. The approach is risk-based, with narrow scope per 2003 FDA guidance, enforcing core controls while exercising discretion on some elements.

Key Components

Subparts: General provisions, electronic records (closed/open systems), electronic signatures.
Core controls: validation (§11.10(a)), audit trails (§11.10(e)), access limits (§11.10(d)), operational/authority/device checks (§11.10(f)-(h)), training (§11.10(i)), signature linking (§11.70).
Built on ALCOA+ principles for data integrity; no formal certification, but inspection readiness required.

Why Organizations Use It

Mandatory for electronic reliance in pharma, devices, biologics to avoid enforcement.
Enhances data integrity, supports inspections, reduces recalls.
Builds trust, enables digital transformation, aligns with global standards like EU Annex 11.

Implementation Overview

Phased: scoping, gap analysis, validation (IQ/OQ/PQ), SOPs, training.
Applies to life sciences firms using electronic records; risk-based for all sizes.

Key Differences

Aspect	ISO 27001	FDA 21 CFR Part 11
Scope	Information Security Management System across all assets	Electronic records and signatures for FDA predicate rules
Industry	All industries worldwide, any size	Life sciences, pharma, devices, US-regulated
Nature	Voluntary international certification standard	Mandatory US FDA regulation with enforcement
Testing	Risk-based internal audits, certification audits	System validation (IQ/OQ/PQ), FDA inspections
Penalties	Loss of certification, no legal fines	Warning letters, fines, product holds, seizures

Scope

ISO 27001

Information Security Management System across all assets

FDA 21 CFR Part 11

Electronic records and signatures for FDA predicate rules

Industry

ISO 27001

All industries worldwide, any size

FDA 21 CFR Part 11

Life sciences, pharma, devices, US-regulated

Nature

ISO 27001

Voluntary international certification standard

FDA 21 CFR Part 11

Mandatory US FDA regulation with enforcement

Testing

ISO 27001

Risk-based internal audits, certification audits

FDA 21 CFR Part 11

System validation (IQ/OQ/PQ), FDA inspections

Penalties

ISO 27001

Loss of certification, no legal fines

FDA 21 CFR Part 11

Warning letters, fines, product holds, seizures

Frequently Asked Questions

Common questions about ISO 27001 and FDA 21 CFR Part 11

ISO 27001 FAQ

FDA 21 CFR Part 11 FAQ

You Might also be Interested in These Articles...

Step-by-Step Implementation Guide to ISO 27701: Building a Privacy Information Management System (PIMS) on Your ISO 27001 Foundation

Implement ISO 27701 on your ISO 27001 foundation with this actionable guide. Tackle PII controls, audit evidence, GDPR integration. Templates, checklists for 20

You Guide on how to Start Implementing NIS2 in Your Organization

Master NIS2 implementation with our detailed guide. Learn requirements, risk assessment, supply chain security, and compliance steps for your organization. Star

Practical Implementation Blueprint for Regulation S-K Item 106: Cybersecurity Governance and Risk Management Disclosures in 10-Ks

Step-by-step guide for Item 106 cybersecurity disclosures in 10-Ks: risk management, board oversight, Inline XBRL templates (Dec 2024 compliance). Templates for

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how ISO 27001 and FDA 21 CFR Part 11 compare against other standards

Other ISO 27001 Comparisons

Other FDA 21 CFR Part 11 Comparisons

What It Is

Key Components

Mandatory Clauses 4-10 cover context, leadership, planning, support, operation, evaluation, and improvement.

Annex A includes 93 controls grouped into organizational (37), people (8), physical (14), and technological (34) themes.

Built on PDCA cycle for continual improvement.

Optional certification via accredited auditors with Stage 1/2 audits, surveillance, and recertification.

Why Organizations Use It

Enhances resilience against breaches, reduces incident costs (avg. over $5M).

Meets regulatory/contractual needs (e.g., GDPR, NIS2); voluntary but often required for tenders.

Drives competitive edges like 20-30% more bids won, insurance discounts.

Builds stakeholder trust via independent certification.

What It Is

Key Components

Subparts: General provisions, electronic records (closed/open systems), electronic signatures.

Core controls: validation (§11.10(a)), audit trails (§11.10(e)), access limits (§11.10(d)), operational/authority/device checks (§11.10(f)-(h)), training (§11.10(i)), signature linking (§11.70).

Built on ALCOA+ principles for data integrity; no formal certification, but inspection readiness required.

Aspect

ISO 27001

FDA 21 CFR Part 11

Scope

Information Security Management System across all assets

Electronic records and signatures for FDA predicate rules

Industry

All industries worldwide, any size

Life sciences, pharma, devices, US-regulated

Nature

Voluntary international certification standard

Mandatory US FDA regulation with enforcement

Testing

Risk-based internal audits, certification audits

System validation (IQ/OQ/PQ), FDA inspections

Penalties

Loss of certification, no legal fines

Warning letters, fines, product holds, seizures